Potential new treatment for metabolic bone diseases-Exercise and anabolic agents

被引:0
|
作者
Qin, Yi-Xian [1 ]
机构
[1] SUNY Stony Brook, Stony Brook, NY 11794 USA
关键词
D O I
10.1016/j.bone.2008.07.070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S23 / S23
页数:1
相关论文
共 50 条
  • [41] New agents in the Treatment of Myeloma Bone Disease
    Elizabeth S. Ring
    Michelle A. Lawson
    John A. Snowden
    Ingrid Jolley
    Andrew D. Chantry
    Calcified Tissue International, 2018, 102 : 196 - 209
  • [42] CONTRIBUTION OF MORPHOMETRY TO THE EVALUATION OF TREATMENT IN METABOLIC BONE-DISEASES
    OLAH, AJ
    ACTA ANATOMICA, 1981, 111 (1-2): : 107 - 107
  • [43] Fugu parathyroid hormone 1: A potential new anabolic treatment for osteoporosis
    McManus, J. F.
    Davey, R. A.
    McLean, H. L.
    Sims, N. A.
    Bouxsein, M. L.
    Zajac, J. D.
    Danks, J. A.
    BONE, 2007, 40 (06) : S157 - S157
  • [44] An Efficient Synthesis of 3-Aryl-2 H -chromene Derivatives as Potential Bone Anabolic Agents
    Khanka, Sonu
    Rawat, Kundan S.
    Pandey, Priyanka
    Pal, Shyamal
    Vats, Ravi P.
    Rathur, Rajat
    Sharma, Kriti
    Dipali, Divya
    Singh, Divya
    Goel, Atul
    SYNLETT, 2025,
  • [45] Therapeutic Potential of Natural Pharmacological Agents in the Treatment of Human Diseases
    Ramana, Kota V.
    Singhal, Sharad S.
    Reddy, Aramati B.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [46] D-PINITOL/D-CHIRO-INOSITOL IS A POTENTIAL THERAPEUTIC AGENT FOR THE TREATMENT OF METABOLIC BONE DISEASES
    Rho, J.
    Yu, J.
    Choi, S.
    Park, E-S
    Shin, B.
    Yu, J.
    Kim, J.
    Yun, H.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S763 - S764
  • [47] Naringenin is a Potential Anabolic Treatment for Bone Loss by Modulating Osteogenesis, Osteoclastogenesis, and Macrophage Polarization
    Zhou, Xin
    Zhang, Zheng
    Jiang, Weiwei
    Hu, Miao
    Meng, Yichen
    Li, Wenfang
    Zhou, Xuhui
    Wang, Ce
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [48] Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
    Giacoppo, Sabrina
    Mandolino, Giuseppe
    Galuppo, Maria
    Bramanti, Placido
    Mazzon, Emanuela
    MOLECULES, 2014, 19 (11): : 18781 - 18816
  • [49] Postbiotics as potential new therapeutic agents for metabolic disorders management
    Bourebaba, Yasmina
    Marycz, Krzysztof
    Mularczyk, Malwina
    Bourebaba, Lynda
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [50] CLOSING THE GAP IN THE TREATMENT OF PATIENTS AT IMMINENT RISK OF FRACTURE: ROLE OF THE NEW ANABOLIC AGENTS
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S33 - S33